...World TB Day 2023 Marks the
Start of a New Era: Yes! We Can End TB!
GENEVA/VARANASI (24 March 2023)—The Stop TB Partnership today issued a positive World TB Day reset, ‘Yes! We Can End TB,’ to rally the international community to end tuberculosis (TB) by 2030. The Stop TB Partnership Board and partners convened for the first time during World TB Day in Varanasi, India—the country with the highest TB burden but also with high political commitment, ambition, hard work and a robust plan to end TB. On the sidelines of the One World TB Summit, the board and partners embraced a post-pandemic call to action that will see new efforts, research, tools and innovations put into practice.
“The theme of the G20 is a resolution for the shared future of the entire world,” said the Honorable Prime Minister Shri Narendra Modi at the One World TB Summit today. He underlined that it is realizing the resolutions of global good with the One World TB Summit.
“India’s efforts are a new model for the global war on TB. People’s participation in the fight against TB is India’s big contribution. India is now working on the target of ending TB by the year 2025. I would like that more and more countries get the benefit of all campaigns, innovations and modern technology of India,” added the Prime Minister.
During the Board meeting, a high-level advocacy platform will be announced by the Stop TB Partnership: the Coalition of Leaders to End TB. Constructed on the leadership of India’s Prime Minister Narendra Modi, the coalition will include Heads of State and Government that are champions of the TB response at national, regional and global levels. Among the leaders whose representatives are negotiating this coalition are President Joko Widodo of Indonesia, President Lula da Silva of Brazil, President Cyril Ramaphosa of South Africa, and the newly elected President of Nigeria, Bola Tinubu. The Coalition of Leaders will be formally launched during the United Nations (UN) General Assembly week in New York City in September 2023.
In 2022, several of the high TB burden countries—including Brazil, Nigeria, India and Indonesia—diligently increased the number of people diagnosed and enrolled on TB treatment, reaching and exceeding the numbers seen before the COVID-19 pandemic. According to preliminary data from the Stop TB Partnership, in 2022 the gap between the estimated number of people with TB and those diagnosed and treated was the lowest ever—with less than 3 million missing people with TB. This gap was 3.2 million in 2019, 4.3 million in 2020, and 4.2 million in 2021.
Despite this progress, last year, as the COVID-19 pandemic ebbed, TB regained its tragic title as the world’s biggest infectious disease killer due to setbacks in diagnosis and treatment over the past three years. This year is critical as the international community prepares for the next UN High Level Meeting (UNHLM) on TB taking place in September 2023, the second such event held at the UN General Assembly.
- Rapid
molecular tests that can identify TB and resistance patterns in the
bacteria;
- Shorter
treatment regiments, for drug-sensitive and drug-resistant infections;
- New
digital tools, such as AI enabled ultraportable X-ray systems for
screening for TB; and
- Vaccine
candidates that have advanced to phase 3 clinical trials.
Globally, investments in TB research and development have
started to climb, surpassing US$1 billion for the first time ever. Advocates
look to the coming UNHLM to boost this momentum and help governments and
funding institutions reach the US$2 billion goal pledged at the first UNHLM,
and further increase to US$5 billion per annum as estimated by the Global Plan
to End TB. And there is growing political momentum on commitment and ambition
from countries like India, Indonesia, Nigeria and South Africa to step up
action at a time when new data shows that every US$1 invested in TB yields
US$46 in benefits.
“What we need is quite simple, given that TB kills 1.6 million people every
year,” added Dr Ditiu. “We need increased political commitments from all high
TB burden countries, and significantly more financing so that we can meet all
the challenges and embark upon a much faster path to new vaccines. We know what
it takes to end TB; we need to roll up our sleeves and make it happen.”
Strong commitments and actions by high TB burden countries
India, the country with the highest TB burden, has displayed a strong ambition
to beat back the disease under the leadership of Prime Minister Modi and
strategic planning and execution of the Minister of Health of India, Dr.
Mansukh Mandaviya, and his team. In 2022, 2.4 million people with TB in India
accessed diagnosis and treatment, which is the highest ever in any year and
signals that India’s TB response has now fully recovered from the impacts of
COVID-19.
“Under the Prime Minister’s TB Free India Campaign, launched in September 2022,
nearly 1 million people with TB have received commitment from individuals in
society who will support them through their treatment journey,” explained
Suvanand Sahu, the deputy executive director of the Stop TB Partnership. “This
initiative is unique in the world and is a great intervention for TB awareness,
stigma elimination, community ownership and crowd funding.”
India has a unique real-time TB information system called NIKSHAY, which is
also linked to direct cash transfers to TB patients. In the last five years,
using this system, US$260 million has been disbursed to nearly 8 million people
with TB to support their nutrition.
The ambitious call from the Prime Minister to end TB in India has driven
innovations in the areas of digital tools, diagnostics, data systems, community
engagement and logistics. Twenty-five of these innovations, developed in the
last two years, will be presented at a session at the Stop TB Board meeting on
March 15 in Varanasi, India. Ownership for implementation has been
decentralized to state, district and village levels, with awards given to
recognize states and districts who are making rapid progress towards ending TB.
People who have gone through the experience of TB are being empowered and made
“TB Champions” for their contributions to end TB in their community. Currently
more than 30,000 TB Champions are supporting the TB response in India.
“India is providing models to fight TB. Trace, Test, Track, Treat and
Technology is the strategy we are implementing to end TB in India by 2025.
India is also producing 80% of TB medicines. India is determined to end TB by
2025...India is ready to work shoulder to shoulder with all other countries and
ensure a better world for future generations,” added Prime Minister Modi.
Indonesia, with the world’s fourth largest burden of TB, also made significant
progress in 2022. Almost three-quarters of the estimated TB caseload was
diagnosed and treated, with the overall treatment success rate at 84%—the
highest rates recorded for Indonesia. Key to the success of the National TB
Program was the deployment of screening campaigns similar to what was used for
COVID-19—pushed through thanks to the political commitment of President Widodo
and Minister of Health Budi Gunadi Sadikin and his TB response team.
During the Board meeting, the Stop TB Partnership will also launch The
Accountability Report of TB-affected Communities and Civil Society: Priorities
to Close the Deadly Divide. This report follows up on the first ever global
community report released in 2020, entitled A Deadly Divide: TB Commitments
vs. TB Realities. The 2023
iteration was coordinated by the Affected Community and NGO Delegations to the
STP Board and featured the mobilization of more than 1,000 civil society and
affected community partners from over 90 countries. Their inputs are reflected
throughout the report in over 30 country case studies and culminate in six
calls to action that are required to end the TB epidemic.
“This report features unprecedented engagement and is written by people with
lived experience of TB and therefore has a legitimacy that cannot be ignored,”
said Dr. Ditiu.
No comments:
Post a Comment